Eisai
4523.T
#2319
Rank
โ‚น810.70 B
Marketcap
โ‚น2,872
Share price
0.08%
Change (1 day)
4.07%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น82.63. In 2026 the company made an earnings per share (EPS) of โ‚น82.27 a decrease over its 2025 EPS that were of โ‚น104.19.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น82.27-21.04%
2025โ‚น104.1911.85%
2024โ‚น93.15-32.63%
2023โ‚น138.275.52%
2022โ‚น131.03-74.01%
2021โ‚น504.12-66.58%
2020โ‚น1,50898.24%
2019โ‚น760.8117.01%
2018โ‚น650.2037.78%
2017โ‚น471.92-27.62%
2016โ‚น652.0235.33%
2015โ‚น481.80-2.82%
2014โ‚น495.80-27.66%
2013โ‚น685.41-27.49%
2012โ‚น945.31-12.67%
2011โ‚น1,08288.08%
2010โ‚น575.55-11.06%
2009โ‚น647.15-390.15%
2008-โ‚น223.04-127.78%
2007โ‚น802.99347.11%
2006โ‚น179.594.38%
2005โ‚น172.077.4%
2004โ‚น160.2243.03%
2003โ‚น112.0225.09%
2002โ‚น89.5552.67%
2001โ‚น58.6569.76%
2000โ‚น34.55